On January 12 a truck pulled out of Rio Tinto's Gudai-Darri iron ore mine in the Pilbara region of Western Australia and drove 1,400km south to Perth, arriving on January 16.
Jan 30, 2023
0
7
Every day, more than 1200 people worldwide are told they have pancreatic cancer. Within 12 months, 80 per cent of them will have succumbed to the disease.
Nov 25, 2019
0
34
Prostate cancer often becomes lethal as it spreads to the bones, and the process behind this deadly feature could potentially be turned against it as a target for bone-targeting radiation and potential new therapies.
May 28, 2019
0
80
Harnessing a probe used to image the brain in diagnosing Alzheimer's disease and related forms of dementia, scientists at Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) have successfully cleared patient-derived ...
Apr 9, 2019
0
40
In Europe, prostate cancer is the most common type of cancer among men with an incidence greater than 100 cases per 100,000 individuals. Furthermore, it is currently the second most common cause of cancer-related deaths among ...
Feb 18, 2019
0
2
A new compound developed at the University of Toronto Scarborough could play an important role in developing cheaper anti-cancer drugs.
Feb 25, 2015
0
4
A team of researchers led by Kai-Hsiang Chuang of the A*STAR Singapore Bioimaging Consortium has developed a new imaging technique to measure the rate at which the brain consumes glucose, without using radioactively labeled ...
Jan 22, 2014
0
0
In theory, the presence of certain chemicals such as mercury can be established by examining nail clippings. Although this is already being done in practice, the method requires greater care than was hitherto thought. That ...
Jul 25, 2013
0
0
Atomic medicine has "fantastic potential" for fighting deadly, difficult to treat cancers, the head of French nuclear giant Areva's medical arm told AFP in an interview.
Jun 10, 2013
0
0
A collaboration between the Paul Scherrer Institute, CERN's ISOLDE facility, and the Institut Laue-Langevin, has published preclinical study results for a newly developed set of tumour-targeting radiopharmaceuticals. The ...
Dec 24, 2012
0
1
